Bio-Techne Announces Agreement to Acquire ProteinSimple
date:Jun 30, 2014
for Western blot use. These reagents tie well into the consumables needs of ProteinSimple customers. This business adds significant benefits by expanding our sales force and signals our desire to participate as an innovative force in the laboratory instruments space, to better leverage our consumables business of high quality reagents.

ProteinSimple Chief Executive Officer, Tim Harkness, added, Strategically, the fit is excellent. Both ProteinSimple and Bio-Techne have a desire to improve life
8/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/23 07:21